The fat-burning zone is real, hard to measure, and not better than training harder

There is a real exercise intensity at which the body oxidises fat fastest — physiologists call it FATmax, and the peak rate at that intensity maximal fat oxidation [s2]. Training there does reduce body fat: a 2026 meta-analysis of 19 randomised trials found body weight down 3.66 kg and body fat down 2.32 percentage points against controls [s1]. What the evidence does not support is the step the marketing takes next — that this intensity is the best one for losing fat. Trials that put moderate continuous training against high-intensity intervals find differences that are small, inconsistent between analyses, and in the largest comparison of body fat percentage, absent [s3] [s4].

The zone exists, and is harder to pin down than a heart-rate chart suggests

A 2025 narrative review in the International Journal of Obesity examined how reliably maximal fat oxidation and its corresponding intensity can actually be measured, pooling 11 studies of reproducibility in healthy people and in people with obesity [s2]. Both measures appear reduced in individuals with obesity and cardiometabolic disease, and correlate with insulin resistance or sensitivity, muscle oxidative capacity and adipose tissue lipolysis [s2].

The review's central concern is methodological. It stresses standardising pre-test macronutrient intake and physical activity, discusses which exercise protocols and analytical procedures minimise measurement error, and raises the possibility that the reported day-to-day variation in these measures may in part simply represent the measurement error of the gas analysers used to derive them [s2]. That matters for anyone told their fat-burning zone is a particular heart rate: the underlying quantity moves with what you ate yesterday and how you trained, and is measured with equipment whose precision the field is still arguing about.

Training in the zone works

The 2026 systematic review, registered on PROSPERO and searching PubMed, Cochrane, Embase, SPORTDiscus and Web of Science through 6 December 2025, pooled 19 randomised trials of 644 participants with overweight or obesity, using a three-level random-effects model [s1].

Against controls, training at FATmax reduced body weight by 3.66 kg, body mass index by 1.66 kg/m², body fat percentage by 2.32 percentage points, fat mass by 2.86 kg and waist circumference by 4.21 cm, all at p < 0.01 [s1]. It improved maximal oxygen uptake (standardised mean difference 1.45) and reduced fasting glucose (SMD −1.28), insulin (SMD −0.53) and HOMA-IR (SMD −0.57) [s1]. Non-linear dose-response modelling identified an optimal total exercise volume of about 2,446 minutes for maximal body composition benefit [s1].

Two caveats belong with those numbers. The controls were largely non-exercising, so the comparison establishes that this training beats not training — not that it beats other training. And the overall GRADE ratings were predominantly very low to moderate, with the authors noting that standardised assessment protocols are still needed [s1].

Against harder training, the picture is mixed

Two meta-analyses have put interval training directly against moderate continuous training for fat loss, and they do not fully agree.

A 2023 review restricted to randomised trials that measured body composition by DXA pooled 11 trials in adults with excess weight [s3]. It found no greater benefit of intervals on body fat percentage (mean difference −0.55%, 95% CI −1.42 to 0.31, p = 0.209) and none on abdominal visceral fat (SMD −0.05, 95% CI −0.29 to 0.19) [s3]. Intervals did show advantages on maximal oxygen uptake, total cholesterol and fasting glucose [s3].

An earlier and larger 2019 analysis in the British Journal of Sports Medicine pooled 36 trials [s4]. Within groups, both approaches cut body fat percentage — intervals by 1.50 points (95% CI −2.14 to −0.86) and moderate continuous training by 1.44 (−2.00 to −0.89) — with no significant difference between them (−0.23, 95% CI −1.43 to 0.97, p = 0.705) [s4]. On absolute fat mass in kilograms, however, the difference favoured intervals (−2.28 kg, 95% CI −4.00 to −0.56, p = 0.0094), and sprint interval protocols specifically outperformed moderate training (−3.22 kg, 95% CI −5.71 to −0.73) [s4]. The authors summarised this as intervals producing 28.5% greater reductions in total absolute fat mass [s4].

So one analysis finds no difference on either measure, and the other finds none on percentage body fat but a difference on absolute fat mass. That is not a resolved question, and anyone presenting it as one — in either direction — is overstating what two meta-analyses of modest trials can establish.

What the zone claim gets wrong

The fat-burning zone argument runs: at moderate intensity a larger share of the energy you burn comes from fat, therefore moderate intensity is the intensity for losing fat. The first half is a description of substrate use during the session. The second half is a claim about body composition weeks later, and it is that claim the trials test.

When they do, the ranking the substrate argument predicts does not reliably appear. Training at FATmax produces real reductions in fat mass [s1]. So does training well above it [s3] [s4]. The variable the trials keep returning to is how much training was done — the 2026 review's dose-response curve is built on total exercise volume, not on intensity alone [s1].

This article is informational and is not medical advice.

Sources

• Exercise Training at Maximal Fat Oxidation Intensity for Body Composition and Cardiometabolic Health in People With Overweight and Obesity — Scandinavian Journal of Medicine & Science in Sports, 2026-02-24
• Methodological issues related to maximal fat oxidation and FATmax reproducibility: a narrative review — International Journal of Obesity, 2025-07-24
• High-intensity interval training is not superior to continuous aerobic training in reducing body fat — Journal of Exercise Science & Fitness, 2023-09-17
• Is interval training the magic bullet for fat loss? — British Journal of Sports Medicine, 2019-02-14